PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study

AIM: To describe the clinical management and PD-L1 testing of patients with newly diagnosed stage IV non-small cell lung cancer (NSCLC) without driver mutations in Spain. METHODS: Multicenter, retrospective study. RESULTS: Among 297 evaluated patients, 89.2% received systemic treatment for stage IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio-Viqueira, Belen, Tarruella, Margarita Majem, Lázaro, Martín, Estévez, Sergio Vázquez, Córdoba-Ortega, Juan Felipe, Maiques, Inmaculada Maestu, González, Jorge García, Cordellat, Ana Blasco, Valdivia-Bautista, Javier, Arenas, Carmen González, Sánchez Torres, Jose Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656292/
https://www.ncbi.nlm.nih.gov/pubmed/34899993
http://dx.doi.org/10.2217/lmt-2021-0008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656292/
https://www.ncbi.nlm.nih.gov/pubmed/34899993
http://dx.doi.org/10.2217/lmt-2021-0008

Ejemplares similares